DIN 02368250 — TASIGNA 150 MG
TASIGNA is a capsule of Nilotinib marketed by NOVARTIS PHARMACEUTICALS CANADA INC. The full Nilotinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02368250
- Brand name
- TASIGNA
- Active ingredient
- Nilotinib
- Strength
- 150 MG
- Dosage form
- CAPSULE
- Route
- ORAL
- Manufacturer
- NOVARTIS PHARMACEUTICALS CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Protein kinase inhibitor (BCR-ABL tyrosine kinase inhibitor)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Nilotinib products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02550881 | APO-NILOTINIB | 150 MG | CAPSULE | APOTEX INC | MARKETED |
| 02550903 | APO-NILOTINIB | 200 MG | CAPSULE | APOTEX INC | MARKETED |
| 02556634 | REDDY-NILOTINIB | 150 MG | CAPSULE | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02556642 | REDDY-NILOTINIB | 200 MG | CAPSULE | DR REDDY'S LABORATORIES LTD | MARKETED |
| 02315874 | TASIGNA | 200 MG | CAPSULE | NOVARTIS PHARMACEUTICALS CANADA INC | MARKETED |